Medications for Migraine Disorders

123 results
  • Aimovig

    (erenumab-aooe)
    Amgen Inc
    Usage: AIMOVIG is indicated for the preventive treatment of migraines in adults.
  • Ajovy

    (fremanezumab-vfrm)
    Teva Pharmaceuticals USA, Inc.
    Usage: AJOVY is indicated for the preventive treatment of migraines in adults.
  • Cambia

    (diclofenac potassium)
    Assertio Therapeutics, Inc.
    Usage: CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not intended for prophylactic therapy of migraine or for the treatment of cluster headache.
  • Cambia (diclofenac potassium)

    (Diclofenac Potassium)
    Nautilus Neurosciences, Inc.
    Usage: CAMBIA™ (Diclofenac Potassium for Oral Solution) is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not recommended for prophylactic therapy or for cluster headaches.
  • Depakote

    (Divalproex Sodium)
    AbbVie Inc.
    Usage: Depakote ER is indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment. Considerations regarding pregnancy and potential risks are crucial for women of childbearing potential.
  • Depakote (divalproex sodium)

    (Divalproex Sodium)
    REMEDYREPACK INC.
    Usage: Depakote ER is indicated for treating acute manic or mixed episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in complex partial and absence seizures in patients aged 10 and older. It is also approved for migraine prophylaxis but not for acute treatment.
  • Leading Pharma, LLC
    Usage: Diclofenac Potassium is indicated for the acute treatment of migraine attacks with or without aura in adults. It is not intended for prophylactic therapy of migraines or for treating cluster headaches, as its safety and effectiveness for that condition have not been established.
  • Torrent Pharmaceuticals Limited
    Usage: Diclofenac potassium for oral solution is indicated for the acute treatment of migraine attacks in adults (18 years and older), with or without aura. It is not intended for migraine prophylaxis or for treating cluster headaches.
  • Cipla USA Inc.
    Usage: Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches, with or without aura. It is not intended for prophylactic therapy or for the management of hemiplegic or basilar migraines.
  • Contract Pharmacy Services-PA
    Usage: Divalproex Sodium Delayed-Release Tablets are indicated for treating manic episodes of bipolar disorder, managing complex partial and absence seizures, and preventing migraine headaches. Its safety for long-term use in mania is not systematically evaluated, and caution is advised for women of childbearing potential.